96 results
8-K
EX-1.1
MDGL
Madrigal Pharmaceuticals Inc
7 May 24
Entry into a Material Definitive Agreement
4:36pm
with a court or government authority, no investigation with respect to which the Company has received written notice, and no written notice by any … , investigation, arbitration or other action from any governmental authority or third party alleging that any product operation or activity is in violation of any
424B3
MDGL
Madrigal Pharmaceuticals Inc
7 May 24
Prospectus supplement
4:34pm
paid or discounts or concessions allowed to such broker-dealer(s), where applicable, (v) that such broker-dealer(s) did not conduct any investigation
S-3ASR
EX-4.6
MDGL
Madrigal Pharmaceuticals Inc
7 May 24
Automatic shelf registration
4:06pm
as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based … ;
(c) a statement that, in the opinion of each such individual, he has made such examination or investigation as is necessary to enable him
8-K
EX-1.1
gdnj q0ude
20 Mar 24
Entry into a Material Definitive Agreement
4:11pm
8-K
EX-1.1
7xg0jsxfeyec
2 Oct 23
Entry into a Material Definitive Agreement
5:15pm
424B5
sln39iijluquoai
2 Oct 23
Prospectus supplement for primary offering
5:10pm
424B5
6t17w9zemnpv6w7rdw48
28 Sep 23
Prospectus supplement for primary offering
4:01pm
8-K
EX-10.1
s4em1f 974wf5gz
13 Sep 23
Departure of Directors or Certain Officers
4:30pm
424B3
fmv c2d0m5j1
8 Aug 23
Prospectus supplement
9:19am
8-K
EX-10.1
2yf5709a8k5
23 Dec 22
Madrigal Pharmaceuticals Announces $300+ Million in Financing Events to Advance Resmetirom Program
7:00am
8-K
EX-1.1
0bvwap
1 Jun 21
Entry into a Material Definitive Agreement
8:01am